{"product_id":"thrombosis-forum-right-heart-symposium-2023","title":"Thrombosis Forum Right Heart Symposium 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3\u003eNorth American Thrombosis Forum Right Heart Symposium 2023\u003c\/h3\u003e\n\u003cbr\u003eNorth American Thrombosis Forum Right Heart Symposium 2023 Pulmonary vascular disease (PVD), including pre- and post-capillary pulmonary hypertension, are a spectrum of progressive, symptomatic, and ultimately fatal disorders for which significant advances in treatment have been made. Despite advances in the management of PVD, the mortality rate remains disproportionate.\u003cbr\u003e\u003cbr\u003eEvaluation and treatment are often delayed until patients present with serious complications. Effective management requires timely recognition, accurate diagnosis, and selection of the different therapeutic options.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Include: 31 videos + 1 pdf, size: 11.7 GB\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eProgression to right ventricular dysfunction and finally failure can occur as an acute event in consequences where the pulmonary hypertension develops acutely as with pulmonary embolism, or because of a chronic condition such as pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension (CTEPH), chronic obstructive pulmonary disease (COPD), interstitial lung disease, or chronic left sided heart or valvular disease.\u003cbr\u003e\u003cbr\u003eEarly detection and appropriate management can improve quality of life and may improve survival. Medical therapy has come a long way towards decreasing symptoms, enhancing performance, and improving prognosis, but there is still a long way to go, especially for the broader population of patients with PVD.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTARGET AUDIENCE\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis program is tailored to clinical and research professionals who study and\/or care for patients with right heart disease, congenital heart disease, pulmonary hypertension, and associated disorders.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLEARNING OBJECTIVES\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAt the end of this program, participants should be able to:\u003cbr\u003e\u003col type=\"1\"\u003e\n\u003cli\u003eReview the options for advanced imaging approaches to assess and monitor RV function and pulmonary vascular remodeling\u003c\/li\u003e\n\u003cli\u003eDescribe pharmacologic interventions to augment or restore RV function in the patient with advanced PVD or critical illness\u003c\/li\u003e\n\u003cli\u003eAssess the latest interventional, device, and pharmacologic approaches to PVD and evaluate these options in various forms of PVD, including disease-modifying pathways such as PDGF and TGF-beta signaling\u003c\/li\u003e\n\u003cli\u003eDiscuss advanced hemodynamic and physiologic correlates of right ventricular-pulmonary arterial coupling\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003cbr\u003eAssessing RV Function and Response to Treatment Advanced Imaging Approaches to Assessing Pulmonary Vascular Remodeling and RV Function.mp4\u003cbr\u003eAssessing RV Function and Response to Treatment Assessing the RV- It’s All in the Curves.mp4\u003cbr\u003eAssessing RV Function and Response to Treatment Assessing the RV- It’s the Dots, Not the Curves- Focus on Speckle Tracking and Strain Imaging.mp4\u003cbr\u003eAssessing RV Function and Response to Treatment Is There a Role for PET or Molecular Imaging to Assess the RV.mp4\u003cbr\u003eAssessing RV Function and Response to Treatment Panel Discussion.mp4\u003cbr\u003eKEYNOTE PRESENTATION Assessing Right Ventricular Function Using Exercise, Imaging, and Hemodynamics.mp4\u003cbr\u003eNovel Interventional and Pharmaceutical Approaches In the Age of Disease Modifiers, What Should our Approach to Treatment be.mp4\u003cbr\u003eNovel Interventional and Pharmaceutical Approaches Intrapulmonary Artery Balloon Pump – Why and When.mp4\u003cbr\u003eNovel Interventional and Pharmaceutical Approaches Panel discussion.mp4\u003cbr\u003eNovel Interventional and Pharmaceutical Approaches Targeting BMPR2.mp4\u003cbr\u003eNovel Interventional and Pharmaceutical Approaches Targeting Metabolism – is it a Viable Target.mp4\u003cbr\u003ePulmonary Embolism Clot In Transit – What is the Optimal Approach.mp4\u003cbr\u003ePulmonary Embolism Optimal Duration of Anticoagulation – 2 months; 3 months; life long.mp4\u003cbr\u003ePulmonary Embolism Panel discussion.mp4\u003cbr\u003ePulmonary Embolism Provoked and Unprovoked – What is the Difference, and does it Matter.mp4\u003cbr\u003ePulmonary Embolism What does Clot Burden Mean.mp4\u003cbr\u003ePulmonary Non-Hypertensive Vascular Pathology Anomalous Venous Return – Diagnosis and Management.mp4\u003cbr\u003ePulmonary Non-Hypertensive Vascular Pathology Left to Right Shunting and Enhanced Pulmonary Blood Flow – Why is the Patient Dyspneic.mp4\u003cbr\u003ePulmonary Non-Hypertensive Vascular Pathology Panel discussion.mp4\u003cbr\u003ePulmonary Non-Hypertensive Vascular Pathology Pulmonary Artery Aneurysm – is it a Surgical Disease.mp4\u003cbr\u003ePulmonary Non-Hypertensive Vascular Pathology Pulmonary AVM’s without HHT.mp4\u003cbr\u003eThe Art of Hemodynamics – What does the RHC Really Tell Us Clinical Implications of Aggressive Afterload Reduction.mp4\u003cbr\u003eThe Art of Hemodynamics – What does the RHC Really Tell Us Panel discussion.mp4\u003cbr\u003eThe Art of Hemodynamics – What does the RHC Really Tell Us Pulmonary Artery Hemodynamics- the Action is in the Proximal Vasculature.mp4\u003cbr\u003eThe Art of Hemodynamics – What does the RHC Really Tell Us Pulmonary Artery Hemodynamics- the Action is in the Small Vessels.mp4\u003cbr\u003eThe Art of Hemodynamics – What does the RHC Really Tell Us RV-PA Coupling, Afterload, and Pressure-Volume Curves.mp4\u003cbr\u003eThe Failing Right Heart – What Are the Realistic Salvage Options Inotropic Support in RV Failure – Is There Really a Role.mp4\u003cbr\u003eThe Failing Right Heart – What Are the Realistic Salvage Options Panel discussion.mp4\u003cbr\u003eThe Failing Right Heart – What Are the Realistic Salvage Options Vasopressor Support in RH Failure – Can We Optimize RV Mechanics and Coronary Perfusion.mp4\u003cbr\u003eThe Failing Right Heart – What Are the Realistic Salvage Options When and why is the RV too Sick for Lung Transplantation.mp4\u003cbr\u003eThe Failing Right Heart – What Are the Realistic Salvage Options When to Consider MCS – Hemodynamic, Physiologic, and Patient Selection.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954394370146,"sku":"MED-AMB02600","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/North-American-Thrombosis-Forum-Right-Heart-Symposium-2023.jpg?v=1779375307","url":"https:\/\/meducourse.com\/products\/thrombosis-forum-right-heart-symposium-2023","provider":"Meducourse","version":"1.0","type":"link"}